Literature DB >> 11846787

The processivity and fidelity of DNA synthesis exhibited by the reverse transcriptase of bovine leukemia virus.

Orna Avidan1, Michal Entin Meer, Iris Oz, Amnon Hizi.   

Abstract

We have recently expressed in bacteria the enzymatically active reverse transcriptase (RT) of bovine leukemia virus (BLV) [Perach, M. & Hizi, A. (1999) Virology 259, 176-189]. In the present study, we have studied in vitro two features of the DNA polymerase activity of BLV RT, the processivity of DNA synthesis and the fidelity of DNA synthesis. These properties were compared with those of the well-studied RTs of human immunodeficiency virus type 1 (HIV-1) and murine leukaemia virus (MLV). Both the elongation of the DNA template and the processivity of DNA synthesis exhibited by BLV RT are impaired relative to the other two RTs studied. Two parameters of fidelity were studied, the capacity to incorporate incorrect nucleotides at the 3' end of the nascent DNA strand and the ability to extend these 3' end mispairs. BLV RT shows a fidelity of misinsertion higher than that of HIV-1 RT and lower than that of MLV RT. The pattern of mispair elongation by BLV RT suggests that the in vitro error proneness of BLV RT is closer to that of HIV-1 RT. These fidelity properties are discussed in the context of the various retroviral RTs studied so far.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846787     DOI: 10.1046/j.0014-2956.2001.02719.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.

Authors:  Michael E Abram; Andrea L Ferris; Wei Shao; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

2.  A Novel Leu92 Mutant of HIV-1 Reverse Transcriptase with a Selective Deficiency in Strand Transfer Causes a Loss of Viral Replication.

Authors:  Eytan Herzig; Nickolay Voronin; Nataly Kucherenko; Amnon Hizi
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 3.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

4.  The mechano-chemistry of a monomeric reverse transcriptase.

Authors:  Omri Malik; Hadeel Khamis; Sergei Rudnizky; Ariel Kaplan
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

5.  Expression and site-directed mutagenesis of the lactococcal abortive phage infection protein AbiK.

Authors:  Louis-Charles Fortier; Julie D Bouchard; Sylvain Moineau
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

6.  Rate-limiting Pyrophosphate Release by HIV Reverse Transcriptase Improves Fidelity.

Authors:  An Li; Shanzhong Gong; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2016-10-24       Impact factor: 5.157

7.  Effect of ribonucleotides embedded in a DNA template on HIV-1 reverse transcription kinetics and fidelity.

Authors:  Waaqo Daddacha; Erin Noble; Laura A Nguyen; Edward M Kennedy; Baek Kim
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

8.  The role of phenylalanine-119 of the reverse transcriptase of mouse mammary tumour virus in DNA synthesis, ribose selection and drug resistance.

Authors:  Michal Entin-Meer; Ziv Sevilya; Amnon Hizi
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

9.  Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage.

Authors:  Varuni K Jamburuthugoda; Jose M Santos-Velazquez; Mark Skasko; Darwin J Operario; Vandana Purohit; Pauline Chugh; Erika A Szymanski; Joseph E Wedekind; Robert A Bambara; Baek Kim
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

10.  Pausing kinetics dominates strand-displacement polymerization by reverse transcriptase.

Authors:  Omri Malik; Hadeel Khamis; Sergei Rudnizky; Ailie Marx; Ariel Kaplan
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.